About
Chris is a private equity M&A Partner in our global M&A and capital group.
He advises sponsors, LPs and corporates on a wide range of transactional matters, including minority and majority investments and exits, consortium arrangements, take-privates and management incentivisation.
He has worked with many of the firm’s key private capital clients across a range of sectors and has particular experience guiding clients through investments into businesses with a global footprint, leading on transactions across Europe, the US, MENA and Asia.
Chris trained at Freshfields and spent two years seconded to the corporate group in Amsterdam.
Additional Information
- Permira on its significant minority investment in Carne Group, Europe’s largest independent third-party management company;
- Advent on the sale of Zentiva, a European generics business, to GTCR, and on the earlier acquisition by Zentiva of Alvogen’s CEE business;
- Blackstone and Goldman Sachs Alternatives on the sale of Prima, the Italian direct insurance business, to AXA;
- CVC on its IPO on Euronext Amsterdam and prior corporate reorganisation;
- CD&R and Motor Fuel Group on the £2.5 billion acquisition of forecourts and electric vehicle charging sites from Morrisons;
- Permira and Blackstone on a €14 billion take-private offer for Adevinta ASA, a European online classifieds business, and on Adevinta's sale of its shares in Distilled, Ireland's leading online classifieds company;
- Permira on its recommended cash offer for Ergomed plc, a global provider of clinical research, trial management and pharmacovigilance services, and on subsequent add-ons;
- Ontario Teachers' Pension Plan Board on the sales of UK National Lottery operator, Camelot and Irish National Lottery operator, Premier Lotteries Ireland;
- CVC on its investment in Spectrum Medical Group, a provider of technology for cardiac bypass and ICU settings;
- CVC on its €4.5 billion acquisition of ekaterra, the global Unilever Teas business;
- Warburg Pincus and Apax on their €5.1 billion acquisition of T-Mobile Netherlands;
- IK Partners on its sale of VPS to Fremman Capital;
- Vitruvian Partners on its acquisition of a majority equity stake in Expereo and on the sale of Voxbone to Bandwidth Inc.;
- Getronics on its restructuring and sale to GSH Private Capital;
- TSSP and Lifetri Group on the acquisition of Klaverblad life insurance;
- CVC on its acquisition of a stake in Webpros from Oakley Capital;
- GIC on its significant minority investment in Galderma, the skin health business carved-out of Nestlé;
- CVC on its investments in Premiership Rugby, PRO14 Rugby and Six Nations, and its disposal of Formula One to Liberty Media;
- Advent on its disposal of Ammeraal Beltech to Partners Group;
- Amex Global Business Travel on its take-private of London-listed Hogg Robinson plc;
- Warburg Pincus on its acquisition of Supplier Assessment Services; and
- Acadia Healthcare on its sale of 22 healthcare facilities to BC Partners.
Christopher Yarrow
Partner
London Office
100 Bishopsgate
London EC2P 2SR